U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2017
411
Substance Class Protein
Created
by admin
on Mon Mar 31 22:16:00 GMT 2025
Edited
by admin
on Mon Mar 31 22:16:00 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
28X28X9OKV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
durvalumab [INN]
Preferred Name English
DURVALUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
DURVALUMAB [USAN]
Common Name English
IMFINZI
Brand Name English
DURVALUMAB [JAN]
Common Name English
MEDI-4736
Code English
DURVALUMAB [PURPLE BOOK CDER]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN B7-H1) (HUMAN MONOCLONAL MEDI4736 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI4736 .KAPPA.-CHAIN, DIMER
Common Name English
DURVALUMAB [MI]
Common Name English
MEDI4736
Code English
Durvalumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MEDI4736 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI4736 .KAPPA.-CHAIN, DIMER
Common Name English
Classification Tree Code System Code
WHO-ATC L01XC28
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
NDF-RT N0000193338
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
FDA ORPHAN DRUG 785220
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
NCI_THESAURUS C128057
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
FDA ORPHAN DRUG 721519
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
FDA ORPHAN DRUG 691319
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
Code System Code Type Description
DAILYMED
28X28X9OKV
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
INN
10010
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
EVMPD
SUB176342
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
LACTMED
Durvalumab
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
CAS
1428935-60-7
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
WIKIPEDIA
Durvalumab
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
NCI_THESAURUS
C103194
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
FDA UNII
28X28X9OKV
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
RXCUI
1919503
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
USAN
AB-135
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
ChEMBL
CHEMBL3301587
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
DRUG BANK
DB11714
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
MERCK INDEX
m12004
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
DRUG CENTRAL
5234
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
SMS_ID
100000162511
Created by admin on Mon Mar 31 22:16:00 GMT 2025 , Edited by admin on Mon Mar 31 22:16:00 GMT 2025
PRIMARY
From To
1_22 1_96
1_148 1_204
1_224 3_215
1_230 2_230
1_233 2_233
1_265 1_325
1_371 1_429
2_22 2_96
2_148 2_204
2_224 4_215
2_265 2_325
2_371 2_429
3_23 3_89
3_135 3_195
4_23 4_89
4_135 4_195
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details
PROGRAMMED CELL DEATH 1 LIGAND 1
TARGET -> INHIBITOR
Related Record Type Details
DURVALUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NONGLYCOSYLATED CHEMICAL
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966